SC Pharmaceuticals Inc (SCPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.00 -0.01 (-0.33%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.99 -0.01 (-0.33%) 19:45 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
Operating Expenses | 32,905 | 29,667 | 23,436 | 17,910 | 10,844 |
Operating Income | -32,905 | -29,667 | -23,436 | -17,910 | -10,844 |
Interest Expense | 1,767 | 1,432 | 797 | 6,512 | 0 |
Other Income | 1,676 | 1,656 | 416 | 45 | 326 |
Pre-tax Income | -32,996 | -29,443 | -23,817 | -24,377 | -10,518 |
Net Income Continuous | -32,996 | -29,443 | -23,817 | -24,377 | -10,518 |
Net Income | $-32,996 | $-29,443 | $-23,817 | $-24,377 | $-10,518 |
EPS Basic Total Ops | -1.77 | -1.59 | -8.04 | -25.01 | -13.78 |
EPS Basic Continuous Ops | -1.77 | -1.59 | -8.04 | -25.01 | -13.78 |
EPS Diluted Total Ops | -1.77 | -1.59 | -8.04 | -25.01 | -13.78 |
EPS Diluted Continuous Ops | -1.77 | -1.59 | -8.04 | -25.01 | -13.78 |
EPS Diluted Before Non-Recurring Items | -1.77 | -1.59 | N/A | N/A | N/A |
EBITDA(a) | $-32,541 | $-29,335 | $-23,269 | $-17,814 | $-10,840 |